Literature DB >> 11431303

Lesson of the week: Depot corticosteroid treatment for hay fever causing avascular necrosis of both hips.

S M Nasser1, P W Ewan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11431303      PMCID： PMC1120627          DOI： 10.1136/bmj.322.7302.1589

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  15 in total

1.  Prophylaxis of summer hay-fever and asthma: a controlled trial comparing crude grass-pollen extracts with the isolated main protein component.

Authors:  A W FRANKLAND; R AUGUSTIN
Journal:  Lancet       Date:  1954-05-22       Impact factor: 79.321

2.  A double-blind, placebo-controlled study of immunotherapy with grass-pollen extract Alutard SQ during a 3-year period with initial rush immunotherapy.

Authors:  I Dolz; C Martínez-Cócera; J M Bartolomé; M Cimarra
Journal:  Allergy       Date:  1996-07       Impact factor: 13.146

3.  Avascular necrosis of the femoral head secondary to corticosteroid therapy for graft-versus-host disease after marrow transplantation: effective therapy with hip arthroplasty.

Authors:  K Atkinson; M Cohen; J Biggs
Journal:  Bone Marrow Transplant       Date:  1987-12       Impact factor: 5.483

4.  Hyposensitisation in grass pollen hay fever. A double blind trial of alumn precipitated pollen extract and depot emulsion pollen extract compared with placebo injections.

Authors:  M K McAllen
Journal:  Acta Allergol       Date:  1969-12

5.  Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. III. Efficacy and safety of unfractionated and high-molecular-weight preparations in rhinoconjunctivitis and asthma.

Authors:  J Bousquet; H J Maasch; A Hejjaoui; W Skassa-Brociek; R Wahl; H Dhivert; F B Michel
Journal:  J Allergy Clin Immunol       Date:  1989-10       Impact factor: 10.793

6.  Long-term clinical efficacy of grass-pollen immunotherapy.

Authors:  S R Durham; S M Walker; E M Varga; M R Jacobson; F O'Brien; W Noble; S J Till; Q A Hamid; K T Nouri-Aria
Journal:  N Engl J Med       Date:  1999-08-12       Impact factor: 91.245

Review 7.  Any place for depot triamcinolone in hay fever?

Authors: 
Journal:  Drug Ther Bull       Date:  1999-03

8.  Prevalence of asthma and hay fever in England and Wales.

Authors:  D M Fleming; D L Crombie
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-31

9.  Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs.

Authors:  V A Varney; M Gaga; A J Frew; V R Aber; A B Kay; S R Durham
Journal:  BMJ       Date:  1991-02-02

10.  Osteonecrosis of the femoral head in patients with inflammatory arthritis or asthma receiving corticosteroid therapy.

Authors:  C W Colwell; C A Robinson; D D Stevenson; V C Vint; B A Morris
Journal:  Orthopedics       Date:  1996-11       Impact factor: 1.390
View more
  10 in total

Review 1.  Glucocorticoid-induced osteonecrosis.

Authors:  Robert S Weinstein
Journal:  Endocrine       Date:  2011-12-15       Impact factor: 3.633

2.  [Mechanism of action of nasal glucocorticosteroids in the treatment of allergic rhinitis. Part 2: Practical aspects of application].

Authors:  L von Bernus; P Högger; O Pfaar; L Klimek
Journal:  HNO       Date:  2012-08       Impact factor: 1.284

Review 3.  Steroid induced osteonecrosis: An analysis of steroid dosing risk.

Authors:  Christian Powell; Christopher Chang; Stanley M Naguwa; Gurtej Cheema; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2010-07-09       Impact factor: 9.754

Review 4.  Mechanisms and clinical implications of glucocorticosteroids in the treatment of allergic rhinitis.

Authors:  M Okano
Journal:  Clin Exp Immunol       Date:  2009-08-06       Impact factor: 4.330

Review 5.  Optimal management of allergic rhinitis.

Authors:  Glenis K Scadding
Journal:  Arch Dis Child       Date:  2015-04-02       Impact factor: 3.791

Review 6.  Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action.

Authors:  Mohammad Amin Kerachian; Chantal Séguin; Edward J Harvey
Journal:  J Steroid Biochem Mol Biol       Date:  2009-02-21       Impact factor: 4.292

Review 7.  Intramuscular corticosteroid injections in seasonal allergic rhinitis: A systematic review.

Authors:  Ahmed B Bayoumy; Felicia van Schie; Inge Stegeman; Esther B Blijleven; Erwin L van der Veen; Jacob A de Ru
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-09-04

8.  Gluteal subcutaneous atrophy after depot steroid injection for allergic rhinitis.

Authors:  Rohan Ameratunga
Journal:  World Allergy Organ J       Date:  2012-11       Impact factor: 4.084

9.  BSACI guidelines for the management of allergic and non-allergic rhinitis.

Authors:  G K Scadding; S R Durham; R Mirakian; N S Jones; S C Leech; S Farooque; D Ryan; S M Walker; A T Clark; T A Dixon; S R A Jolles; N Siddique; P Cullinan; P H Howarth; S M Nasser
Journal:  Clin Exp Allergy       Date:  2008-01       Impact factor: 5.018

Review 10.  Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper.

Authors:  Valerie Hox; Evelijn Lourijsen; Arnout Jordens; Kristian Aasbjerg; Ioana Agache; Isam Alobid; Claus Bachert; Koen Boussery; Paloma Campo; Wytske Fokkens; Peter Hellings; Claire Hopkins; Ludger Klimek; Mika Mäkelä; Ralph Mösges; Joaquim Mullol; Laura Pujols; Carmen Rondon; Michael Rudenko; Sanna Toppila-Salmi; Glenis Scadding; Sophie Scheire; Peter-Valentin Tomazic; Thibaut Van Zele; Martin Wagemann; Job F M van Boven; Philippe Gevaert
Journal:  Clin Transl Allergy       Date:  2020-01-03       Impact factor: 5.871
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.